参考文献/References:
[1]臧岭,汤夏冰.鼻内镜术后采用激素治疗慢性鼻窦炎鼻息肉的临床效果评价[J].中国药物与临床,2016,16(5):683-685.[2]许航宇,舒海荣,宋建新.慢性鼻-鼻窦炎鼻息肉内镜手术前后组织中血管内皮生长因子和黏蛋白MUC5AC的表达情况[J].中国内镜杂志,2016,22(12):70-74.[3]何清泉,李振安,余凤慈.鼻内镜鼻窦手术对鼻窦炎鼻息肉患者嗅觉功能及鼻腔容积的影响[J].山东大学耳鼻喉眼学报,2016,30(1):58-60,63.[4]王慧敏,蔡纪堂,李静波,等.感染不同病原菌对慢性鼻-鼻窦炎伴鼻息肉患者内镜手术疗效及相关血清指标的影响研究[J].中华医院感染学杂志,2016,26(21):4935-4937.[5]刘鹤,李永.经鼻内镜手术结合药物治疗慢性鼻窦炎伴鼻息肉的疗效观察[J].中国临床医生杂志,2016,44(11):64-66.[6]孔维封,郑瑞,邓慧仪,等.慢性鼻-鼻窦炎伴鼻息肉的临床特征分析[J].中国耳鼻咽喉头颈外科,2019,26(12):4.[7]吴文,陈涵.鼻内镜手术改善鼻窦炎鼻息肉患者鼻腔梗阻症状及嗅觉功能的作用[J].河北医学,2016,22(5):759-761.[8]Wang C,Lou H,Wang X,et al.Effect of budesonide transnasal nebulization in patients with eosinophilic chronic rhinosinusitis with nasal polyps[J].J Allergy Clin Immunol,2015,135(4):922-929.e6. [9]刘勇.鼻内镜手术结合玉屏风颗粒治疗慢性鼻窦炎伴鼻息肉的疗效及对免疫功能的影响[J].安徽医药,2017,21(2):339-342.[10]王旭,朱晓朴,朱晓燕,等.糖皮质激素联合内镜治疗对鼻息肉患者炎症因子的影响[J].贵州医科大学学报,2016,41(12):1459-1461,1465.[11]韩建军,任何贤,邓丽.术前应用糖皮质激素对慢性鼻-鼻窦炎伴鼻息肉患者组织TGF、HIF-1α、VEGF表达的影响研究[J].中华生物医学工程杂志,2016,22(6):502-506.[12]柯昌平.糖皮质激素短疗程雾化吸入对嗜酸粒细胞性鼻窦炎伴鼻息肉患者相关指标的影响[J].实用临床医药杂志,2018,22(9):89-92.[13]邓晓奕,徐开伦,任贤灵.鼻内镜联合局部应用曲安奈德鼻喷雾剂治疗鼻息肉患者疗效及复发率的观察[J].中华全科医学,2015,13(8):1266-1282.[14]刘恒惠.糖皮质激素联合鼻内镜术治疗鼻息肉的临床疗效观察[J].现代诊断与治疗,2015,26(19):4444-4445.[15]孙恒亚,刘涛.慢性鼻-鼻窦炎鼻息肉患者围手术期口服糖皮质激素时长对鼻内镜手术近期疗效的影响[J].河北医科大学学报,2017,38(6):695-698,704.
相似文献/References:
[1]钟时嘉.亚急性甲状腺炎的临床分析[J].医学信息,2018,31(01):181.[doi:10.3969/j.issn.1006-1959.2018.01.073]
ZHONG Shi-jia.Clinical Analysis of Subacute Thyroiditis[J].Medical Information,2018,31(23):181.[doi:10.3969/j.issn.1006-1959.2018.01.073]
[2]梁恒伟,温丽慧,吕 忠,等.鼻内镜术后联合置管冲洗治疗真菌性上颌窦炎的疗效观察[J].医学信息,2018,31(04):104.[doi:10.3969/j.issn.1006-1959.2018.04.035]
LIANG Heng-wei,WEN Li-hui,LV Zhong,et al.Clinical Observation on the Treatment of Fungal Maxillary Sinusitis after Nasal Endoscopy Combined with Catheterization and Rinsing[J].Medical Information,2018,31(23):104.[doi:10.3969/j.issn.1006-1959.2018.04.035]
[3]唐培渊,宋俊峰,秦克乐,等.难治性特发性血小板减少性紫癜的治疗进展[J].医学信息,2018,31(05):42.[doi:10.3969/j.issn.1006-1959.2018.05.016]
TANG Pei-yuan,SONG Jun-feng,QIN Ke-le,et al.Progress in Treatment of Refractory Idiopathic Thrombocytopenic Purpura[J].Medical Information,2018,31(23):42.[doi:10.3969/j.issn.1006-1959.2018.05.016]
[4]苗艳茹.甲巯咪唑与糖皮质激素联合治疗甲状腺功能亢进症合并症的效果分析[J].医学信息,2018,31(05):136.[doi:10.3969/j.issn.1006-1959.2018.05.048]
MIAO Yan-ru.Analysis of Effects of Methimazole and Glucocorticoids on Complications of Hyperthyroidism[J].Medical Information,2018,31(23):136.[doi:10.3969/j.issn.1006-1959.2018.05.048]
[5]康 凯,郑继伟,王 闰.糖皮质激素治疗甲亢伴浸润性突眼的疗效分析[J].医学信息,2018,31(08):103.[doi:10.3969/j.issn.1006-1959.2018.08.033]
KANG Kai,ZHENG Ji-wei,WANG Run.Efficacy of Glucocorticoids in the Treatment of Hyperthyroidism with Infiltrating Exophthalmos[J].Medical Information,2018,31(23):103.[doi:10.3969/j.issn.1006-1959.2018.08.033]
[6]赵 维,廖荣宏,王爱华.糖皮质激素治疗心力衰竭疗效与安全性的Meta分析[J].医学信息,2018,31(14):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
ZHAO Wei,LIAO Rong-hong,WANG Ai-hua.Meta-analysis of the Efficacy and Safety of Glucocorticoids in the Treatment of Heart Failure[J].Medical Information,2018,31(23):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
[7]刘广涛,关凤军,董 晨.原发性肾病综合征患儿肾组织P-gp170蛋白和mRNA表达与临床病理及预后的关系[J].医学信息,2018,31(21):61.[doi:10.3969/j.issn.1006-1959.2018.21.017]
LIU Guang-tao,GUAN Feng-jun,DONG Chen.Relationship between the Expression of p-gp170 Protein and mRNA in Renal Tissue of Children with Primary Nephrotic Syndrome and Clinical Pathology and Prognosis[J].Medical Information,2018,31(23):61.[doi:10.3969/j.issn.1006-1959.2018.21.017]
[8]陈晓霞,唐 勇,胡 庆,等.吗替麦考酚酯联合糖皮质激素治疗特发性膜性肾病的疗效观察[J].医学信息,2018,31(22):89.[doi:10.3969/j.issn.1006-1959.2018.22.024]
CHEN Xiao-xia,TANG Yong,HU Qing,et al.Therapeutic Effect of Mycophenolate Mofetil Combined with Glucocorticoid on Idiopathic Membranous Nephropathy[J].Medical Information,2018,31(23):89.[doi:10.3969/j.issn.1006-1959.2018.22.024]
[9]高 鹏,高 浩,燕 飞.坏疽性脓皮病1例[J].医学信息,2019,32(01):191.[doi:10.3969/j.issn.1006-1959.2019.01.063]
[10]马艳艳,刘建军.肌无力危象的治疗研究进展[J].医学信息,2019,32(06):45.[doi:10.3969/j.issn.1006-1959.2019.06.016]
MA Yan-yan,LIU Jian-jun.Progress in the Treatment of Myasthenia Crisis[J].Medical Information,2019,32(23):45.[doi:10.3969/j.issn.1006-1959.2019.06.016]